APA (7th ed.) Citation

Hacking, N., Vigneswaran, G., Maclean, D., Bryant, T., Umranikar, S., Cheong, Y., & Modi, S. (2022). The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent. Human Fertility, 25(5), 881. https://doi.org/10.1080/14647273.2021.1920055

Chicago Style (17th ed.) Citation

Hacking, Nigel, Ganesh Vigneswaran, Drew Maclean, Timothy Bryant, Sameer Umranikar, Ying Cheong, and Sachin Modi. "The Impact on Anti-Mullerian Hormone (AMH), Uterine Fibroid Size and Uterine Artery Patency Following Uterine Fibroid Embolization (UFE) with a Resorbable Embolic Agent." Human Fertility 25, no. 5 (2022): 881. https://doi.org/10.1080/14647273.2021.1920055.

MLA (9th ed.) Citation

Hacking, Nigel, et al. "The Impact on Anti-Mullerian Hormone (AMH), Uterine Fibroid Size and Uterine Artery Patency Following Uterine Fibroid Embolization (UFE) with a Resorbable Embolic Agent." Human Fertility, vol. 25, no. 5, 2022, p. 881, https://doi.org/10.1080/14647273.2021.1920055.